- Simple to use: The handheld RetinaVue™ 100 imager is simple to use; any healthcare professional can obtain high-resolution fundus images in 5 minutes or less. A full diagnostic report is uploaded through a secure link. Results are typically available in 90 minutes from a board-certified retinal specialist. A simple 4-step process makes operation easy:
- Affordable: At a price two-thirds less than desktop fundus cameras, the handheld RetinaVue 100 Imager makes retinal assessment in primary care settings practical. Four of the top five commercial healthcare payers provide coverage for RetinaVue diabetic retinopathy screening. Many providers enjoy a favorable return on investment within their first year. Coding options for digital retinal exams (DRE) include CPT codes 92250, 92227 and 92228. Verify specific reimbursement with your payer plans.
- Effective: Patient compliance rates for diabetic retinal assessment can double in 12 months with RetinaVue, helping to preserve vision and increase quality metrics. Welch Allyn is the only nationwide diabetic retinopathy diagnostic services company exclusively using fellowship-trained, board-certified, retina specialists. Plus, annual diabetic retinal exams are included in the NCQA HEDIS, Medicare Advantage Stars and Medicare Medicare quality rating programs.
Download the white paper, “Improving Access to Potentially Vision-Saving Diabetic Retinopathy Screening Technology,” to read more about practice benefits.